JAK2 and acquired polycythemia vera: Unexpectedly, the PV phenotype was modified; this involved both the reversal of splenomegaly and osteomyelofibrosis, and a reduction in marrow HSC, despite the biallelic expression of functional MPL expressing JAK2 V617F.